Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcadia Biosciences, Inc.RKDA · Entity 8593 | Director | August 19, 2024 | August 21, 2024 |
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Chief Executive Officer | May 23, 2022 | May 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcadia Biosciences, Inc.
Report date August 19, 2024 · Filed August 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2034-08-19 | Direct | 13,394 |
Reported balance
After 2024-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-19 · Grant · Acquired 10,909 · Balance 13,394 F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.
LIFECORE BIOMEDICAL, INC. \DE\
Report date May 23, 2022 · Filed May 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,883 |
Ending reported balance
After 2022-05-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-23 · Exercise / conversion · Acquired 55,000 · Balance 100,152 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Row 2 · 2022-05-23 · Tax withholding · Disposed 27,269 · Balance 72,883 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Common StockSEC Table II · derivative / convertible security · Expires 2022-05-23 | Direct | 0 |
Reported balance
After 2022-05-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-23 · Exercise / conversion · Disposed 55,000 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on May 23, 2019. F3: The restricted stock units vested on May 23, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on May 23, 2019.
F3: The restricted stock units vested on May 23, 2022.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SunOpta Inc.
Report date May 01, 2026 · Filed May 04, 2026
Section 16 reporting ended · disclosed 2026-05-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Disposition to issuer · Disposed 233,283 · Balance 0 F1: Pursuant to the Arrangement Agreement (the "Arrangement Agreement"), dated as of February 6, 2026, by and among SunOpta Inc. ("SunOpta"), Pegasus BidCo B.V. ("Parent") and 2786694 Alberta Ltd. ("Purchaser"), Purchaser acquired all of SunOpta's issued and outstanding common shares in the capital of SunOpta (the "Common Shares") by way of a court-approved statutory plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement"). At the effective time of the Arrangement (the "Effective Time"), each of SunOpta's issued and outstanding Common Shares were transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings (the "Consideration"). |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Disposition to issuer · Disposed 20,193 · Balance 0 F2: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F3: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Arrangement Agreement (the "Arrangement Agreement"), dated as of February 6, 2026, by and among SunOpta Inc. ("SunOpta"), Pegasus BidCo B.V. ("Parent") and 2786694 Alberta Ltd. ("Purchaser"), Purchaser acquired all of SunOpta's issued and outstanding common shares in the capital of SunOpta (the "Common Shares") by way of a court-approved statutory plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement"). At the effective time of the Arrangement (the "Effective Time"), each of SunOpta's issued and outstanding Common Shares were transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings (the "Consideration").
F2: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
F3: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 4, 2026 17:29 UTC | SunOpta Inc. STKL · Entity 49798 | Disposition to issuerRestricted Stock Unit (RSU) · Derivative | 20,193 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000351834-26-000113 · form4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,193 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F3 · price: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU. F3 · derivative.exercise_date: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU. F3 · derivative.expiration_date: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU. Read SEC document |
| May 01, 2026 Filed May 4, 2026 17:29 UTC | SunOpta Inc. STKL · Entity 49798 | Disposition to issuerCommon Stock | 233,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000351834-26-000113 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Arrangement Agreement (the "Arrangement Agreement"), dated as of February 6, 2026, by and among SunOpta Inc. ("SunOpta"), Pegasus BidCo B.V. ("Parent") and 2786694 Alberta Ltd. ("Purchaser"), Purchaser acquired all of SunOpta's issued and outstanding common shares in the capital of SunOpta (the "Common Shares") by way of a court-approved statutory plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement"). At the effective time of the Arrangement (the "Effective Time"), each of SunOpta's issued and outstanding Common Shares were transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings (the "Consideration"). Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 01:36 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,637 | $6.47 | $10,591.39 |
DisclosureSEC source: 0000351834-26-000087 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,283 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 16:26 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,662 | $6.39 | $10,620.18 |
DisclosureSEC source: 0000351834-26-000009 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,646 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 16:27 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,806 | $5.68 | $10,258.08 |
DisclosureSEC source: 0000351834-25-000007 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,984 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:03 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-013194 · form4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,193 Underlying: Common Shares · 20,193 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F3 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:03 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,810 | $6.64 | $12,018.40 |
DisclosureSEC source: 0001062993-25-013194 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,178 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| May 29, 2025 Filed May 30, 2025 20:55 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 20,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010584 · form4.xml · derivative · entry 3 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| May 29, 2025 Filed May 30, 2025 20:55 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 17,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010584 · form4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,770 Underlying: Common Shares · 17,770 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| May 29, 2025 Filed May 30, 2025 20:55 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 20,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-25-010584 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:00 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,186 | $3.90 | $8,525.40 |
DisclosureSEC source: 0001062993-25-007709 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,296 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| January 24, 2025 Filed Jan 28, 2025 00:03 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,360 | $7.38 | $10,036.80 |
DisclosureSEC source: 0001062993-25-001132 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,110 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 23:09 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,629 | $6.02 | $9,806.58 |
DisclosureSEC source: 0001062993-24-017854 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,750 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 23:14 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 10,909 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000950170-24-099619 · ownership.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,394 Underlying: Common Stock · 10,909 shares Expires 2034-08-19 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| July 26, 2024 Filed Jul 29, 2024 21:05 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,912 | $5.23 | $9,999.76 |
DisclosureSEC source: 0001062993-24-014136 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,121 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| May 30, 2024 Filed May 31, 2024 23:54 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 15,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011592 · form4.xml · derivative · entry 3 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| May 30, 2024 Filed May 31, 2024 23:54 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 15,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-011592 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| May 29, 2024 Filed May 31, 2024 23:54 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 20,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011592 · form4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,072 Underlying: Common Shares · 20,072 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 24, 2024 00:28 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,337 | $5.96 | $7,968.52 |
DisclosureSEC source: 0001062993-24-008733 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,926 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:29 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,679 | $6.03 | $10,124.37 |
DisclosureSEC source: 0001062993-24-001614 · form4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,589 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 20:21 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,726 | $3.37 | $9,186.62 |
DisclosureSEC source: 0001209191-23-053458 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,910 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 28, 2023 Filed Jul 31, 2023 20:45 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,317 | $6.22 | $8,191.74 |
DisclosureSEC source: 0001209191-23-043833 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,184 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:03 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 14,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035348 · doc4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 14,018 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:03 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 14,018 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035348 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 06, 2023 Filed Jun 16, 2023 17:06 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 937 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-23-037757 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,485 Underlying: Common Stock · 937 shares Expires 2033-06-06 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 20:56 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 15,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033364 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,283 Underlying: Common Shares · 15,283 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:06 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,144 | $8.14 | $9,312.16 |
DisclosureSEC source: 0001209191-23-025517 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,849 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:25 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,044 | $8.21 | $8,571.24 |
DisclosureSEC source: 0001209191-23-007278 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,705 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:51 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 968 | $9.93 | $9,612.24 |
DisclosureSEC source: 0001209191-22-054430 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,661 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 29, 2022 Filed Aug 3, 2022 13:29 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,111 | $8.82 | $18,619.02 |
DisclosureSEC source: 0001209191-22-044040 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,693 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:01 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 14,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035343 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,018 Underlying: Common Shares · 14,018 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:52 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 7,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034282 · doc4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 7,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:52 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 7,503 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034282 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:49 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 23,620 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001209191-22-034126 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,018 Underlying: Common Stock · 23,620 shares Expires 2032-06-01 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 23, 2022 Filed May 24, 2022 19:05 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock · Derivative | 55,000 | $9.45 | $519,750.00 |
DisclosureSEC source: 0001628280-22-015279 · wf-form4_165341911696810.xml · derivative · entry 3 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 23, 2019. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2022. F3 · derivative.expiration_date: The restricted stock units vested on May 23, 2022. Read SEC document |
| May 23, 2022 Filed May 24, 2022 19:05 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 27,269 | $9.45 | $257,692.05 |
DisclosureSEC source: 0001628280-22-015279 · wf-form4_165341911696810.xml · nonDerivative · entry 2 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,883 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2022 Filed May 24, 2022 19:05 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 55,000 | $9.45 | $519,750.00 |
DisclosureSEC source: 0001628280-22-015279 · wf-form4_165341911696810.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| April 22, 2022 Filed Apr 27, 2022 00:56 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 3,429 | $5.48 | $18,790.92 |
DisclosureSEC source: 0001209191-22-025698 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,079 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:28 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,536 | $6.95 | $17,625.20 |
DisclosureSEC source: 0001209191-22-007451 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,650 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 22:11 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,008 | $8.78 | $17,630.24 |
DisclosureSEC source: 0001209191-21-061683 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,114 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 30, 2021 Filed Aug 4, 2021 01:03 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,437 | $12.26 | $17,617.62 |
DisclosureSEC source: 0001209191-21-049508 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,106 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 22:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 91,763 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001593968-21-001896 · primary_01.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,763 Underlying: Common Stock · 91,763 shares Expires 2028-07-27 Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 22:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantIncentive Stock Option (right to buy) · Derivative | 8,237 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001593968-21-001896 · primary_01.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,237 Underlying: Common Stock · 8,237 shares Expires 2028-07-27 Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:23 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 19,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043156 · doc4.xml · derivative · entry 2 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,503 Underlying: Common Shares · 19,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:23 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 19,547 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-043156 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 19:48 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 10,935 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-21-038166 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,398 Underlying: Common Stock · 10,935 shares Expires 2031-06-02 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:33 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 7,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038009 · doc4.xml · derivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,503 Underlying: Common Shares · 7,503 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 19:54 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,188 | $14.84 | $17,629.92 |
DisclosureSEC source: 0001209191-21-028250 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,122 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 21:45 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 9,000 | $10.61 | $95,490.00 |
DisclosureSEC source: 0001593968-21-001118 · primary_01.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,152 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.52 to $10.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| January 29, 2021 Filed Feb 3, 2021 01:59 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,510 | $11.67 | $17,621.70 |
DisclosureSEC source: 0001209191-21-007014 · doc4.xml · nonDerivative · entry 1 Bolles Albert D. · CIK 0001603163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,934 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.